Participating in the Startup Showdown presented by TechUnited:NJ and Tech Council Ventures on September 17, 2020, Lambent Data won the Audience Choice Award! Thanks so much again to the audience members who voted for us! Many thanks again to TechUnited:NJ and Tech Council Ventures for this wonderful opportunity and to the investors for their valuable questions and feedback!
NJ Tech Weekly also covered this event in detail, including Lambent's pitch and Audience Choice Award. See the NJTech Weekly article and photo of the "Zoom Room" on-camera participants, including Lambent's Co-founder and CEO Kirsten Hund Blair, at https://njtechweekly.com/three-nj-startups-compete-in-latest-techunitednj-startup-showdown/
The virtual event focused on companies addressing "Real World Data / Evidence," and included Data Biologics and WellCare Today LLC, along with Lambent Data. The investors included Mark Kolb, Entrepreneur-in-Residence at Tech Council Ventures; Steven Cohen, Managing Partner of Morgan Lewis; and Ren Roome, Principal of Boston Millenial Partners. In addition to the live Zoom meeting allowing for audience "Chat" and "Q and A," the event was Live-Streamed on TechUnited:NJ's Facebook page.
Lambent's Co-founder and CEO Kirsten Hund Blair pitched during 5 minutes, including debuting Lambent Data's "Launch Video," and answered questions from the investors and audience for about 10 minutes.
At the end of the event, Moderator Jasmine Hoffman, Head of Experience for TechUnited:NJ, announced that Lambent Data had won the Audience Choice Award!
Ms. Hoffman and Ana Mazumdar, Marketing & Experience Manager for TechUnited:NJ, have been skillfully organizing this Startup Showdown Series, which premiered April 23, 2020. A Special Edition of Startup Showdown will occur during the amazing October 5-9, 2020 Propelify Festival, also being organized by them and their colleagues at TechUnited:NJ. For more info about Propelify, please see https://techunited.co/event/propelify/; it is free to register to attend.
For further info on Lambent Data, including investment opportunities, please contact Kirsten Hund Blair at email@example.com -- many thanks!